Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06455332

Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

Evaluation of the Predictive Value of the Optic Nerve Involvement at the Stage of Clinically Isolated Syndrome, for the Diagnosis of Clinically Definite Multiple Sclerosis and the Delay of Second Relapses' Occurrence

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Optic neuritis (ON) represents around 30% of clinical presentation of clinically isolated syndrome (CIS). Asymptomatic optic nerve involvement is very frequent in all stage of multiple sclerosis (MS) disease including the CIS. However, optic nerve is still not part of MS diagnosis criteria. The main objective of our regional and multicenter study is to evaluate the prognostic value of optic nerve involvement at the earliest clinical stage of MS (=CIS) for the diagnosis of clinically definite MS (2nd clinical relapse) and the delay until the 2nd relapse.

Conditions

Interventions

TypeNameDescription
OTHEROptic nerve MRI sequenceSystematic optic nerve MRI sequence during the CIS diagnosis work-up. This sequence is not done systematically and not recommended for now (except in case of acute ON). The interventional nature of the study remains minimal

Timeline

Start date
2025-07-17
Primary completion
2028-07-01
Completion
2028-07-01
First posted
2024-06-12
Last updated
2025-08-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06455332. Inclusion in this directory is not an endorsement.